TY  - JOUR
AU  - Alonso Gómez, Cristina
AU  - Satta, Valentina
AU  - Díez Gutiérrez, Paula
AU  - Fernández Ruiz, Javier
AU  - Sagredo Ezquioga, Onintza
PY  - 2022
DO  - 10.1016/j.neuropharm.2021.108914
SN  - 0028-3908
UR  - https://hdl.handle.net/20.500.14352/71321
T2  - Neuropharmacology
AB  - Dravet Syndrome (DS) is caused by mutations in the Scn1a gene encoding the α1 subunit of the sodium channel Nav1.1, which results in febrile seizures that progress to severe tonic-clonic seizures and associated comorbidities. Treatment with...
LA  - eng
M2  - 108914
PB  - Elsevier
KW  - Behavioural comorbidities
KW  - Cannabinoids
KW  - Dravet syndrome
KW  - Glial reactivity
KW  - Infantile epileptic refractory syndromes
KW  - Seizuring activity
KW  - Syn-Cre/Scn1a(WT/A1783V) mice
KW  - β-caryophyllene.
TI  - Preclinical investigation of β-caryophyllene as a therapeutic agent in an experimental murine model of Dravet syndrome
TY  - journal article
VL  - 205
ER  -